FasL is a catabolic factor in alveolar bone homeostasis.
Karol Alí Apaza AlccayhuamanPatrick HeimelJung-Seok LeeStefan TanglUlrike KuchlerJulie MarchesanLayla PanahipourStefan LettnerEva MatalováReinhard GruberPublished in: Journal of clinical periodontology (2022)
Our findings suggest that FasL is a catabolic factor in alveolar bone homeostasis but it does not affect the inflammatory osteolysis.